During the past decade, Radiation Oncology of Northern Illinois conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 54 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 45 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Radiation Oncology of Northern Illinois" #1 sponsor was "National Cancer Institute (NCI)" with 37 trials, followed by "SWOG Cancer Research Network" with 21 trials sponsored, "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "Gynecologic Oncology Group" with 6 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Radiation Oncology of Northern Illinois" #1 collaborator was "National Cancer Institute (NCI)" with 50 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator and "Agenus Inc." with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Radiation Oncology of Northern Illinois" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Recurrent Breast Carcinoma" (5 trials), "Recurrent Ovarian Carcinoma" (5 trials) and "Breast Cancer" (4 trials). Many other conditions were trialed in "Radiation Oncology of Northern Illinois" in a lesser frequency.

Most popular intervention types in "Radiation Oncology of Northern Illinois" are "Drug" (74 trials), "Other" (63 trials), "Biological" (28 trials), "Procedure" (13 trials) and "Radiation" (11 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (46 trials), "Quality-of-Life Assessment" (17 trials), "Cisplatin" (15 trials), "Carboplatin" (12 trials) and "Docetaxel" (10 trials). Other intervention names were less common.

The vast majority of trials in "Radiation Oncology of Northern Illinois" are 65 trials for "All" genders and 22 trials for "Female" genders.

Currently, there are NaN active trials in "Radiation Oncology of Northern Illinois". undefined are not yet recruiting, 8 are recruiting, 52 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Radiation Oncology of Northern Illinois, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Radiation Oncology of Northern Illinois, 5 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".